Judge Allows Abortion Pill, Mifepristone, To Continue Being Mailed for Now
via HealthDayTHURSDAY, April 9, 2026 — U.S. District Judge David Joseph turned down Louisiana officials’ request to stop mail order delivery of the drug mifepristone nationwide while the case is still in court.
The decision is not final, and the case has been put on hold for now, The Associated Press reported.
Louisiana Attorney General Liz Murrill had asked the court to pause rules from the U.S. Food and Drug Administration (FDA) that allow mifepristone to be ordered online via telehealth and dispensed by mail.
The judge declined, but said the issue could be revisited later.
He also told the FDA to report back within six months as the review of the drug continues.
“Should the agency fail to complete its review … the Court’s analysis … will inevitably change,” he wrote.
Murrill said she plans to appeal, arguing that the current rules cause harm to Louisiana, where abortion is banned at all stages of pregnancy, The Associated Press said.
The judge said the state’s arguments could still succeed in the future, writing that the plaintiffs are "likely to succeed on the merits."
At the same time, abortion rights groups said the ruling isn't final.
“From the courts to the Trump administration to state legislatures across the country, mifepristone and abortion access are very much still under attack,” Planned Parenthood Federation of America President and CEO Alexis McGill Johnson said.
Mifepristone is commonly used with another drug, misoprostol, for medication abortions and to manage miscarriages.
Access to the pill has become a major issue in the wake of the 2022 U.S. Supreme Court decision that allowed states to ban abortion.
But telehealth has played a growing role. One study found that by the end of 2024, about 1 in 4 abortions was accessed through telehealth, a fivefold increase in two years, The Associated Press reported.
What's more, a 2025 study found that women in states with abortion bans were more likely to get pills via mail than to travel to another state.
Some officials have argued that mailing abortion pills could increase risks, including instances where someone is forced to take them.
The case will stay on hold while the FDA continues its review.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-10 09:07
Read more
- Loneliness, Social Isolation Linked to Subjective Cognitive Decline in Perimenopause
- AHA: High Blood Pressure in Young Adulthood Tied to Higher Risk for Cardiovascular Events in Midlife
- Sex Enhancement Chocolates Recalled Over Hidden Drug Ingredients
- Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy
- EAU: Patient Satisfaction Improved With Virtual Reality to Explain Shock Wave Lithotripsy
- Early-Life Exposure to PFAS Linked to Bone Development in Adolescence
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions